Navigation Links
ASTRO Names New Research Director, Health Policy Analyst
Date:9/18/2008

FAIRFAX, Va., Sept. 18 /PRNewswire-USNewswire/ -- The American Society for Therapeutic Radiology and Oncology has welcomed two new additions to its growing staff; Barbara Muth is ASTRO's new director of research and Jennifer Frazier joins the Society as a health policy analyst.

Ms. Muth brings nearly 20 years of healthcare research experience to ASTRO. Prior to joining ASTRO, she worked with the American Red Cross for eight years as the research manager, where she was responsible for prioritizing their research agenda, working with volunteers to establish practice and training guidelines, and designing health and safety studies. She has also held positions with the Lombardi Comprehensive Cancer Center at Georgetown University in Washington and Memorial Sloan-Kettering Cancer Center in New York, managing the NCI-funded National Hispanic Leadership Initiative on Cancer Project, which was the first comprehensive assessment of cancer risk factors among the major populations of Hispanic/Latino men and women in the United States. Also at Memorial Sloan-Kettering, Ms. Muth helped to design a patient navigation program to facilitate cancer detection and treatment for low-income patients. At ASTRO, Ms. Muth will be responsible for leading ASTRO's research team in promoting research, disseminating research results, administrating ASTRO's extensive awards and grants program, and overseeing ASTRO's Research Council and the committees within it.

Ms. Frazier is the newest addition to ASTRO's Health Policy Department. She holds a Master of Public Health degree from the University of Florida at Gainesville, Fla., and before joining ASTRO, she completed a fellowship at the National Cancer Institute in health communications where she helped to plan, develop and promote cancer education programs and materials for the public, cancer patients and health professionals. She has also held a research assistant position with the University of Florida Shands Cancer Center where she worked on two studies examining the impact of cancer on the quality of life of survivors and their families. At ASTRO, Ms. Frazier will be responsible for monitoring the impact of health policy regulatory issues on radiation oncology practices, analyzing health policy regulatory proposals and providing technical assistance to members and their practice managers on practice-related issues. Ms Frazier will also serve as staff liaison to the Emerging Technology Committee and as ASTRO's staff representative to the American Medical Association's Relative Value Update committee.

"We are very excited to have Barbara and Jennifer join our staff," Laura I. Thevenot, ASTRO's chief executive officer, said. "With both of their vast experience in various cancer and public health initiatives, they will be a great asset to the Society and to our members."

ASTRO is the largest radiation oncology society in the world, with more than 9,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy.


'/>"/>
SOURCE American Society for Therapeutic Radiology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Strategies for preventing gastrointestinal complications in severely burned patients
2. How to treat gastroesophageal adenocarcinom patients?
3. Groundbreaking cancer studies to be unveiled at ASTRO annual meeting
4. A new breakthrough in timing of urgent endoscopy for gastrointestinal bleeding patients
5. Ondansetron reduces vomiting, hospital admissions in children with gastroenteritis
6. ASTRO selects pediatric oncologist as 2008 honorary member
7. SNM and ASTRO team up to advance molecular imaging and cancer research
8. The Kenneth B. Schwartz Center, ASTRO partner to raise awareness of cancer survivorship
9. Genomma Lab Internacional Acquires UNIGASTROZOL
10. Sports Luminaries Andre Agassi, Jerry Rice, Scottie Pippen, Helio Castrovenes, Richard Goose Gossage Among Those Named 2008 Great Sports Legends
11. MDCT, virtual gastroscopy and MPR images differentiate malignant and benign gastric ulcers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: